S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of 506U78 in treating patients who have
recurrent or refractory acute lymphocytic leukemia.